GENZ » Topics » Gross Margin

This excerpt taken from the GENZ 8-K filed Feb 14, 2007.

Gross Margin

Genzyme’s non-GAAP gross margin is expected to be approximately 77-78 percent of revenue this year, consistent with the gross margin for 2006.

This excerpt taken from the GENZ 8-K filed Feb 17, 2005.

Gross Margin

        Total gross margin is expected to be in the range of 77-78 percent of revenue, compared with 74 percent in 2004. Several factors account for this increase: improved product margins for Synvisc, improved margins for Renagel resulting from the transition to in-house manufacturing, and improved margins for lysosomal storage disorder products resulting from increased utilization of manufacturing facilities.


Feb 14, 2007
Feb 17, 2005
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki